-+ 0.00%
-+ 0.00%
-+ 0.00%

Personalis Presents NeXT Personal ctDNA Data At AACR 2026 Showing 100% Sensitivity In Colorectal Cancer Monitoring

Benzinga·04/21/2026 10:10:25
Listen to the news
  • Podium presentation on NeXT Personal monitoring neoadjuvant therapy in colorectal cancer;
  • Real-world data from 10,000 patients reinforce industry-leading sensitivity;
  • Data presented for a new NeXT Personal feature for monitoring resistance mutations